Author:
Hoshino Junichi,Ubara Yoshifumi,Sawa Naoki,Sumida Keiichi,Hiramatsu Rikako,Hasegawa Eiko,Suwabe Tatsuya,Hayami Noriko,Yamanouchi Masayuki,Takemoto Fumi,Taniguchi Shuichi,Takaichi Kenmei
Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Nephrology,Physiology
Reference12 articles.
1. Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995;32:45–59.
2. Falk RH, Comenzo RL, Skinner M. The systemic amyloidosis. N Engl J Med. 1997;337:898–909.
3. Dubrey SW, Cha K, Anderson J, Chamarthi B, Reisinger J, Skinner M, et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM. 1998;91:141–57.
4. Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ, et al. A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med. 1997;336:1202–7.
5. Levy Y, Belghiti-Deprez D, Sobel A. Treatment of AL amyloidosis without myeloma. Ann Med Int Paris. 1988;139:190–3.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献